References
- Baek HH, Kwon SY, Rho SJ, Lee JH, Yang HJ, Hah JM, Kim YR, Yong CS, Choi HG. Enhanced solubility and bioavailability of flurbiprofen by cycloamylose. Arch Pharm Res 2012; 35(4)683–9
- Balakrishnan P, Lee BJ, Oh DH, Kim JO, Hong MJ, Jee JP, Kim JA, Yoo BK, Woo JS, Yong CS, et al. Enhanced oral bioavailability of dexibuprofen by a novel solid SEDDS formulation. Eur J Pharm Biopharm 2009; 72: 539–45
- Choi HG, Oh YK, Kim CK. In-situ gelling and mucoadhesive liquid suppository containing acetaminophen: Enhanced bioavailability. Int J Pharm 1998; 165: 23–32
- Davies NM. Clinical pharmacokinetics of flurbiprofen and its enantiomers. Clin Pharmacokinet 1995; 28: 100–14
- Grau MJ, Kayser O, Müller RH. Nanosuspensions of poorly soluble drugs – Reproducibility of small scale production. Int J Pharm 2000; 196: 155–7
- Gupta GD, Jain S, Jain NK. Formulation of an aqueous injection of flurbiprofen. Pharmazie 1997; 52: 709–12
- Habib MJ, Phan MT, Owusu-Ababio G. Dissolution profiles of flurbiprofen in phospholipid solid dispersions. Drug Dev Ind Pharm 1998; 24: 1077–82
- Hancock BC, Zografi G. Characteristics and significance of the amorphous state in pharmaceutical systems. J Pharm Sci 1997; 86: 1–12
- Joe JH, Lee WM, Park YJ, Joe KH, Oh DH, Seo YG, Woo JS, Yong CS, Choi HG. Effect of the solid-dispersion method on the solubility and crystalline property of tacrolimus. Int J Pharm 2010; 395: 161–6
- Kim DW, Kang JH, Oh DH, Yang CS, Choi HG. Development of novel flurbiprofen-loaded solid self-microemulsifying drug delivery system using gelatin as solid carrier. J Microencapsul 2012; 29(4)323–30
- Kim CK, Yoon YS. Preparation and evaluation of flurbiprofen dry elixir as a novel dosage form using a spray drying technique. Int J Pharm 1995; 120: 21–31
- Li DX, Han MJ, Balakrishnan P, Yan YD, Oh DH, Joe JH, Seo Y, Kim JO, Park SM, Yong CS, et al. Enhanced oral bioavailability of flurbiprofen by combined use of micelle solution and inclusion compound. Arch Pharm Res 2010a; 33: 95–101
- Li DX, Oh YK, Lim SJ, Kim JO, Yang HJ, Sung JH, Yong CS, Choi HG. Novel gelatin microcapsule with bioavailability enhancement of ibuprofen using spray drying technique. Int J Pharm 2008; 355: 277–84
- Li DX, Yan YD, Oh DH, Yang KY, Seo YG, Kim JO, Kim YI, Yong CS, Choi HG. Development of valsartan-loaded gelatin microcapsule without crystal change using hydroxypropylmethylcellulose as a stabilizer. Drug Deliv 2010b; 17: 322–9
- Newa M, Bhandari KH, Li DX, Kim JO, Yoo DS, Kim JA, Yoo BK, Woo JS, Lyoo WS, Yong CS, et al. Preparation and evaluation of immediate release ibuprofen solid dispersions using polyethylene glycol 4000. Biol Pharm Bull 2008; 31: 939–45
- Noyes AA, Whitney WR. The rate of solution of solid substances in their own solutions. J Am Chem Soc 1897; 19: 930–4
- Oh DH, Balakrishnan P, Oh YK, Kim DD, Yong CS, Choi HG. Effect of process parameters on nanoemulsion droplet size and distribution in SPG membrane emulsification. Int J Pharm 2011; 404: 191–7
- Park KM, Gao ZG, Kim CK. Assay of flurbiprofen in rat plasma using HPLC with fluorescence detection. J Liq Chrom Rel Technol 1997; 20: 1849–55
- Park KM, Lee MK, Hwang KJ, Kim CK. Phospholipid-based microemulsions of flurbiprofen by the spontaneous emulsification process. Int J Pharm 1999; 183: 145–54
- Society of Toxicology (SOT). Guiding principles in the use of animals in toxicology [online]. Available at: www.toxicology.org/AI/FA/guidingprinciples.pdf. Accessed December 2008
- Yang W, Peters JI, Williams RO 3rd. Inhaled nanoparticles-a current review. Int J Pharm 2008; 356: 239–47
- Yan YD, Sung JH, Kim KK, Kim DW, Kim JO, Lee BJ, Yong CS, Choi HG. Novel valsartan-loaded solid dispersion with enhanced bioavailability and no crystalline changes. Int J Pharm 2012; 422: 202–10
- Yong CS, Li DX, Oh DH, Kim JA, Yoo BK, Woo JS, Rhee JD, Choi HG. Retarded dissolution of ibuprofen in gelatin microcapsule by cross-linking with glutaradehyde. Arch Pharm Res 2005; 29: 431–534
- Yuasa H, Takahashi H, Ozeki T, Kanaya Y, Ueno M. Application of the solid dispersion method to the controlled release of medicine. III. Control of the release of slightly water soluble medicine from solid dispersion granules. Chem Pharm Bull 1993; 41: 397–9